Drawing for INTELLION

USPTO serial 97164075

INTELLION

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CLARK, ROBERT C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INTELLION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rosaleen H. Chou

Rosaleen H. Chou Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorKnobbe, Martens, Olson & Bear, LLPIrvine, CA 92614

Goods and services

ClassDescriptionStatusFirst use
042Software-as-a-Service (SaaS) services featuring non-downloadable computer software and Platform-as-a-Service (PaaS) non-downloadable computer software services featuring computer software platforms in the nature of non-downloadable computer software, non-downloadable computer applications, and web-based software, all for accessing cloud-based servers and remote client servers for measuring pre and post-surgical cancer, medical, and disease burden scores through bioinformatics and artificial intelligence, analyzing, testing, tracking, and reporting genetic patterns post-pre- and surgery, providing cancer, medical, and disease treatment recommendation, providing high precision personalized cancer, medical, and disease treatment monitoring throughout the patient cancer, medical, and disease encounter, reducing cancer, medical, and disease treatment costs, and accelerated cancer, medical, and disease drug development for use by pharmaceutical companies and laboratories, health systems, oncologists, physicians, cancer clinics, medical professionals, hospitals, and patientsACTIVE—
044Genetic testing for medical purposes; medical diagnostic testing, monitoring and reporting services; medical testing and diagnostic services, namely, diagnostic testing, monitoring, tracking, and reporting for detecting minimal residual disease (MRD) by analyzing, testing, tracking, and reporting DNA, genomes, genotype, and genetic mutations using whole genome pattern recognition, low-input liquid blood biopsy, aggregated SNC and CNV signals, and tracking tumor progression as it evolves during the patient treatment and follow up periodACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 18, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 18, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 6, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 6, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 6, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 6, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 11, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 8, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 7, 2024EX2GSOU EXTENSION 2 GRANTED—
Mar 7, 2024EXT2SOU EXTENSION 2 FILED—
Mar 7, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 11, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 9, 2023EX1GSOU EXTENSION 1 GRANTED—
Oct 9, 2023EXT1SOU EXTENSION 1 FILED—
Oct 9, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 18, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 5, 2023ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Nov 21, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 25, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 25, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 5, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 17, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2022DOCKASSIGNED TO EXAMINER—
Dec 14, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 13, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance